Cardiovascular disease is the primary cause of death in the United States. Yet many health care providers are still unaware that more women die of cardiovascular disease (CVD) than do men, representing over 500,000 women annually. One in every 2 women will die of a cardiovascular illness. The statistics become even more staggering when you look at a population of higher risk women, such as those with Metabolic Syndrome, with pre-menopausal hypertension, and those with Diabetes Mellitus. The economic costs for the care of this segment of our population will escalate exponentially over the next 3 decades. The implications are great for health care workers, insurance providers, and for pharmaceutical companies.
The Care Group, is committed to educating all levels of health care providers as to the special risks involved for women as evidenced by the Women and Heart Disease Symposium. This symposium is brought to you by The Cardiovascular Research and Education Foundation of Indiana, Inc. (CREFI) and presented by The Care Group, LLC. The goal of the Women and Heart Disease conference is to illustrate the unique development of cardiovascular illnesses in women for primary and secondary prevention, the risk factors, including detection and treatment.
Our target audience includes the primary gatekeepers throughout our three-state area. These providers are usually the first to see women patients including family physicians, internists, gynecologists, nurse practitioners, and nurses. By updating these gatekeepers we can enhance early detection of high-risk patients and educate caregivers as to appropriate early treatment for hypertension, hyperlipidemia, diabetes, coronary disease and Metabolic Syndrome.
Physicians, nurses, pharmacists, dietitians and health professionals interested in women and heart disease.
Morning and afternoon didactic sessions with interactive panel discussion and question and answer period.
Audience will fill out course evaluation that will be tallied and reviewed for future symposiums.